TrialPloS one2020

Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial.

Ngamjit Kasetsuwan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.